Skip to main content
Market intelligence
ONCSector not reported

BeOne Medicines Ltd. insider activity

In the last 90 days, no corporate insiders reported open-market purchases.

SEC-reported filing activity is provided for research purposes and is not investment advice.

90-day C-suite buyers
0
90-day purchase value
$0.00
Corporate buyers
0
Latest transaction
Jun 23, 2026

Executive filings

Open-market transaction history

Purchase and sale summaries are ordered by the latest reported transaction date.

Open-market insider purchase and sale transactions
DateInsider nameRoleTypeSharesPriceTotal value
Jun 23, 2026Lai WangPresident, Global Head of R&DSale1,068$276.74$295,553
Jun 23, 2026Xiaobin WuPresident and COOSale1,292$276.26$356,927
Jun 23, 2026John OylerChief Executive OfficerSale3,410$273.78$933,592